Identification of a novel GSK3 beta specific small molecule inhibitor involved in regulating Wnt beta catenin signaling in KRAS mutant pancreatic cancers

dc.contributor.guide	Mohd Jamal Dar
dc.coverage.spatial
dc.creator.researcher	Mir Owais Ayaz
dc.date.accessioned	2025-02-06T06:58:50Z
dc.date.available	2025-02-06T06:58:50Z
dc.date.awarded	2025
dc.date.completed	2025
dc.date.registered	2019
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent	ALL
dc.identifier.researcherid
dc.identifier.uri	http://hdl.handle.net/10603/620377
dc.language	English
dc.publisher.institution	Biological Sciences (CSIR-IIIM)
dc.publisher.place	Ghaziabad
dc.publisher.university	Academy of Scientific and Innovative Research (AcSIR)
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Biology
dc.subject.keyword	Biology and Biochemistry
dc.subject.keyword	Life Sciences
dc.title	Identification of a novel GSK3 beta specific small molecule inhibitor involved in regulating Wnt beta catenin signaling in KRAS mutant pancreatic cancers
dc.title.alternative	Identification of a novel GSK3-beta specific small molecule inhibitor involved in regulating Wnt/beta-catenin signaling in KRAS mutant pancreatic cancers
dc.type.degree	Ph.D.